Condition
Inherited Retinal Dystrophy Primarily Involving Sensory Retina
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Unknown1
Recruiting1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05626920Phase 1RecruitingPrimary
Disulfiram for Treatment of Retinal Degeneration
NCT03613948CompletedPrimary
Study on the Effects of Mutations Under Inherited Retinal Disease in Korean
NCT04131400UnknownPrimary
Establishment of the National Registry for Inherited Retinal Dystrophy in Iran
NCT03561922Not ApplicableTerminated
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Showing all 4 trials